How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020

Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors (PitNET), are mostly benign, but may present various behaviors: invasive, “aggressive” and malignant with metastases. They are classified into seven morphofunctional types and three lineages: lac...

Full description

Bibliographic Details
Main Authors: Jacqueline Trouillas, Marie-Lise Jaffrain-Rea, Alexandre Vasiljevic, Gérald Raverot, Federico Roncaroli, Chiara Villa
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/2/514
_version_ 1797715428029497344
author Jacqueline Trouillas
Marie-Lise Jaffrain-Rea
Alexandre Vasiljevic
Gérald Raverot
Federico Roncaroli
Chiara Villa
author_facet Jacqueline Trouillas
Marie-Lise Jaffrain-Rea
Alexandre Vasiljevic
Gérald Raverot
Federico Roncaroli
Chiara Villa
author_sort Jacqueline Trouillas
collection DOAJ
description Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors (PitNET), are mostly benign, but may present various behaviors: invasive, “aggressive” and malignant with metastases. They are classified into seven morphofunctional types and three lineages: lactotroph, somatotroph and thyrotroph (PIT1 lineage), corticotroph (TPIT lineage) or gonadotroph (SF1 lineage), null cell or immunonegative tumor and plurihormonal tumors. The WHO 2017 classification suggested that subtypes, such as male lactotroph, silent corticotroph and Crooke cell, sparsely granulated somatotroph, and silent plurihormonal PIT1 positive tumors, should be considered as “high risk” tumors. However, the prognostic impact of these subtypes and of each morphologic type remains controversial. In contrast, the French five-tiered classification, taking into account the invasion, the immuno-histochemical (IHC) type, and the proliferative markers (Ki-67 index, mitotic count, p53 positivity), has a prognostic value validated by statistical analysis in 4 independent cohorts. A standardized report for the diagnosis of pituitary tumors, integrating all these parameters, has been proposed by the European Pituitary Pathology Group (EPPG). In 2020, the pituitary pathologist must be considered as a member of the multidisciplinary pituitary team. The pathological diagnosis may help the clinician to adapt the post-operative management, including appropriate follow-up and early recognition and treatment of potentially aggressive forms.
first_indexed 2024-03-12T08:06:38Z
format Article
id doaj.art-2af61fe8f5ea418280729c12c58527aa
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T08:06:38Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-2af61fe8f5ea418280729c12c58527aa2023-09-02T19:27:56ZengMDPI AGCancers2072-66942020-02-0112251410.3390/cancers12020514cancers12020514How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020Jacqueline Trouillas0Marie-Lise Jaffrain-Rea1Alexandre Vasiljevic2Gérald Raverot3Federico Roncaroli4Chiara Villa5University of Lyon 1, University of Lyon, F-69000 Lyon, FranceBiotechnological and Applied Clinical Sciences Department, University of L’Aquila, 67100 L’Aquila, ItalyUniversity of Lyon 1, University of Lyon, F-69000 Lyon, FranceUniversity of Lyon 1, University of Lyon, F-69000 Lyon, FranceDivision of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, Manchester M13 3PL, UKPathological Department, Foch Hospital, 40 rue Worth Suresnes, 92151 Suresnes, FranceAdenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors (PitNET), are mostly benign, but may present various behaviors: invasive, “aggressive” and malignant with metastases. They are classified into seven morphofunctional types and three lineages: lactotroph, somatotroph and thyrotroph (PIT1 lineage), corticotroph (TPIT lineage) or gonadotroph (SF1 lineage), null cell or immunonegative tumor and plurihormonal tumors. The WHO 2017 classification suggested that subtypes, such as male lactotroph, silent corticotroph and Crooke cell, sparsely granulated somatotroph, and silent plurihormonal PIT1 positive tumors, should be considered as “high risk” tumors. However, the prognostic impact of these subtypes and of each morphologic type remains controversial. In contrast, the French five-tiered classification, taking into account the invasion, the immuno-histochemical (IHC) type, and the proliferative markers (Ki-67 index, mitotic count, p53 positivity), has a prognostic value validated by statistical analysis in 4 independent cohorts. A standardized report for the diagnosis of pituitary tumors, integrating all these parameters, has been proposed by the European Pituitary Pathology Group (EPPG). In 2020, the pituitary pathologist must be considered as a member of the multidisciplinary pituitary team. The pathological diagnosis may help the clinician to adapt the post-operative management, including appropriate follow-up and early recognition and treatment of potentially aggressive forms.https://www.mdpi.com/2072-6694/12/2/514pituitary adenomapituitary tumorclassification of pituitary neuroendocrine tumorsclassification of pituitary tumors
spellingShingle Jacqueline Trouillas
Marie-Lise Jaffrain-Rea
Alexandre Vasiljevic
Gérald Raverot
Federico Roncaroli
Chiara Villa
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Cancers
pituitary adenoma
pituitary tumor
classification of pituitary neuroendocrine tumors
classification of pituitary tumors
title How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
title_full How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
title_fullStr How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
title_full_unstemmed How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
title_short How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
title_sort how to classify pituitary neuroendocrine tumors pitnet s in 2020
topic pituitary adenoma
pituitary tumor
classification of pituitary neuroendocrine tumors
classification of pituitary tumors
url https://www.mdpi.com/2072-6694/12/2/514
work_keys_str_mv AT jacquelinetrouillas howtoclassifypituitaryneuroendocrinetumorspitnetsin2020
AT marielisejaffrainrea howtoclassifypituitaryneuroendocrinetumorspitnetsin2020
AT alexandrevasiljevic howtoclassifypituitaryneuroendocrinetumorspitnetsin2020
AT geraldraverot howtoclassifypituitaryneuroendocrinetumorspitnetsin2020
AT federicoroncaroli howtoclassifypituitaryneuroendocrinetumorspitnetsin2020
AT chiaravilla howtoclassifypituitaryneuroendocrinetumorspitnetsin2020